JP2020508298A - 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat−associated lymphoid cluster) - Google Patents

移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat−associated lymphoid cluster) Download PDF

Info

Publication number
JP2020508298A
JP2020508298A JP2019543979A JP2019543979A JP2020508298A JP 2020508298 A JP2020508298 A JP 2020508298A JP 2019543979 A JP2019543979 A JP 2019543979A JP 2019543979 A JP2019543979 A JP 2019543979A JP 2020508298 A JP2020508298 A JP 2020508298A
Authority
JP
Japan
Prior art keywords
ectopic
cells
subject
tissue
signaling pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019543979A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020508298A5 (cg-RX-API-DMAC7.html
Inventor
ラガス,エリック
Original Assignee
ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション, ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション filed Critical ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Publication of JP2020508298A publication Critical patent/JP2020508298A/ja
Publication of JP2020508298A5 publication Critical patent/JP2020508298A5/ja
Priority to JP2023010078A priority Critical patent/JP7784392B2/ja
Priority to JP2025129210A priority patent/JP2025176014A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
JP2019543979A 2017-02-17 2018-02-20 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat−associated lymphoid cluster) Pending JP2020508298A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023010078A JP7784392B2 (ja) 2017-02-17 2023-01-26 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)
JP2025129210A JP2025176014A (ja) 2017-02-17 2025-08-01 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762460267P 2017-02-17 2017-02-17
US62/460,267 2017-02-17
US201762574119P 2017-10-18 2017-10-18
US62/574,119 2017-10-18
PCT/US2018/018684 WO2018152488A1 (en) 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023010078A Division JP7784392B2 (ja) 2017-02-17 2023-01-26 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)

Publications (2)

Publication Number Publication Date
JP2020508298A true JP2020508298A (ja) 2020-03-19
JP2020508298A5 JP2020508298A5 (cg-RX-API-DMAC7.html) 2021-04-01

Family

ID=63170490

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019543979A Pending JP2020508298A (ja) 2017-02-17 2018-02-20 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat−associated lymphoid cluster)
JP2023010078A Active JP7784392B2 (ja) 2017-02-17 2023-01-26 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)
JP2025129210A Withdrawn JP2025176014A (ja) 2017-02-17 2025-08-01 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023010078A Active JP7784392B2 (ja) 2017-02-17 2023-01-26 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)
JP2025129210A Withdrawn JP2025176014A (ja) 2017-02-17 2025-08-01 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)

Country Status (12)

Country Link
US (2) US20190374583A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582794B1 (cg-RX-API-DMAC7.html)
JP (3) JP2020508298A (cg-RX-API-DMAC7.html)
KR (2) KR102762505B1 (cg-RX-API-DMAC7.html)
CN (2) CN119097642A (cg-RX-API-DMAC7.html)
AU (1) AU2018221254B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019016965A2 (cg-RX-API-DMAC7.html)
CA (1) CA3052295A1 (cg-RX-API-DMAC7.html)
ES (1) ES3070490T3 (cg-RX-API-DMAC7.html)
IL (2) IL268389B2 (cg-RX-API-DMAC7.html)
MX (2) MX2019009367A (cg-RX-API-DMAC7.html)
WO (1) WO2018152488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4427813A3 (en) * 2019-04-11 2024-12-18 University of Pittsburgh- Of the Commonwealth System of Higher Education Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis
WO2023076279A1 (en) * 2021-10-25 2023-05-04 Satellite Biosciences, Inc. Engineered tissue constructs for the treatment of crigler-najjar syndrome
CN116925997B (zh) * 2023-07-27 2024-04-02 湖北医药学院 左氧氟沙星在制备促进细胞增殖中的药物的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110002899A1 (en) * 2008-03-07 2011-01-06 Eric Lagasse Lymph Nodes as a Site for Regeneration
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
US9493532B2 (en) * 2011-12-15 2016-11-15 The University Of Chicago Compositions for cancer therapy using mutant light molecules with increased affinity to receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312691B1 (en) 1996-01-26 2001-11-06 Jeffrey L. Browning Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents
ATE371018T1 (de) * 2001-06-22 2007-09-15 Stemcells Inc Le-zellen (liver engrafting cells), assays und verwendungen davon
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110002899A1 (en) * 2008-03-07 2011-01-06 Eric Lagasse Lymph Nodes as a Site for Regeneration
US9493532B2 (en) * 2011-12-15 2016-11-15 The University Of Chicago Compositions for cancer therapy using mutant light molecules with increased affinity to receptors
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAT. IMMUNOL., 2015, VOL.16, NO.8, PP.819-828, JPN6022002947, ISSN: 0005032085 *

Also Published As

Publication number Publication date
MX2019009367A (es) 2019-10-24
JP7784392B2 (ja) 2025-12-11
KR20250020727A (ko) 2025-02-11
MX2024005097A (es) 2024-05-15
IL268389A (en) 2019-09-26
EP3582794C0 (en) 2026-04-22
JP2025176014A (ja) 2025-12-03
JP2023061960A (ja) 2023-05-02
IL310219A (en) 2024-03-01
US20240091271A1 (en) 2024-03-21
IL310219B1 (en) 2026-03-01
CA3052295A1 (en) 2018-08-23
ES3070490T3 (en) 2026-06-16
WO2018152488A1 (en) 2018-08-23
US20190374583A1 (en) 2019-12-12
AU2018221254B2 (en) 2025-03-20
EP3582794B1 (en) 2026-04-22
BR112019016965A2 (pt) 2020-04-14
EP3582794A4 (en) 2020-12-09
CN119097642A (zh) 2024-12-10
CN110869032B (zh) 2024-08-23
KR20190116439A (ko) 2019-10-14
IL268389B2 (en) 2024-06-01
IL268389B1 (en) 2024-02-01
EP3582794A1 (en) 2019-12-25
CN110869032A (zh) 2020-03-06
AU2018221254A1 (en) 2019-08-15
KR102762505B1 (ko) 2025-02-03
IL310219B2 (en) 2026-07-01

Similar Documents

Publication Publication Date Title
JP7784392B2 (ja) 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)
Sakaida et al. Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice
RU2722361C2 (ru) Органоиды, содержащие изолированные почечные клетки, и их применение
JP5250423B2 (ja) 単離肝幹細胞
JP2022031662A (ja) 膵機能障害の治療または予防方法
US20210024885A1 (en) Methods and compositions for producing hepatocytes
TWI439276B (zh) 肝袓細胞及其使用
US20250144146A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
WO2023180122A1 (en) Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence
WO2014138486A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
CN101356264A (zh) 分离的肝脏干细胞
HK40021179B (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
HK40021179A (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
Eggenhofer et al. Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice
US20250195579A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
Tanimizu et al. Generation of functional liver tissue by establishing hepatobiliary connections ex vivo
Boyd Examining the link between the ductular reaction and fibrosis in fatty liver disease
Selvasandran TNF-α and Hypoxia-Induced Paracrine Secretion of Rat Bone Marrow-Mesenchymal Stem Cells for Cardiac Repair in Lewis Rats Post-Ml

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220601

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230126

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230126

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230207

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230214

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230414

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230418

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250116